The New York State Racing and Wagering Board on May 29 passed proposed restrictions on use of anabolic steroids in racehorses for Thoroughbred and Standardbred racing.
Based on a national model rule supported by the Racing Medication and Testing Consortium and the Association of Racing Commissioners International, the new guidelines would regulate use of four anabolic steroids and establish testing thresholds for each one.
The new guidelines will be forwarded for review and approval to the Governor’s Office of Regulatory Reform. The rule will then be submitted to the Department of State for public comment. The rule will not be adopted by the NYSRWB until completion of a 45-day comment period with the Department of State.
The NYSRWB said the restrictions would allow only one of four steroids to be found in a horse at any given time, and would set the following testing thresholds: stanozolol (Winstrol), one nanogram per milliliter of urine; boldenone (Equipose), 15 ng/ml; nandrolone (Durabolin), one ng/ml; and testosterone, 20 ng/ml in geldings and 55 ng/ml in fillies and mares.
The model rule for steroids has been adopted by about 10 jurisdictions in the United States. On the Thoroughbred side in New York, the regulation when officially adopted will cover horses racing at Aqueduct, Belmont Park, Saratoga, and Finger Lakes Gaming & Racing.